Senior Project Manager

The senior PM expert;

• leads Independently complex, multi-stakeholder studies. 
• Coordinates and harmonizes the work of PMs supporting the study to ensure unified planning and delivery.
• Works with broad internal and external cross-functional teams.
• Acts as Subject Matter Expert (SME) in project management. 
• May oversee multiple complex studies or a client’s full study portfolio.
• Leads and mentors across all PM levels. 
• You may be assigned in the role of Project Director on assigned study. This is a study specific accountability role, and responsibilities should be defined at study level.

Experience - At least 5 years in a PM role (Cross functional role) and able to demonstrate the following:

• Project Management Skills
  • Demonstrated experience planning, executing, and closing projects within scope, time, and budget.
  • Proficiency in risk management, resource allocation, and milestone tracking.
  • Familiarity with project management tools and building timelines understanding interdependencies
  • Development of study plans/review of applicable plans
• Financial Acumen
  • Ability to forecast budgets, monitor burn rates, and manage scope changes.
  • Skilled in cost justification and variance tracking.
• Leadership & Team Management
  • Experience leading cross‑functional teams (Epi, Clinical, DM, Stats, Reg, PVG etc.)
  • Able to resolves conflicts and motivates diverse stakeholders.
  • Promote accountability and collaboration.
• Communication & Stakeholder Engagement
  • Clear, structured communication with sponsors, vendors, any other stakeholders
  • Ability to translate complex requirements into actionable guidance.
  • Understanding of reporting expectations and escalation pathways
• Problem‑Solving & Adaptability
  • Anticipates risks and develops mitigation strategies.
  • Adapts to changes ex. regulatory changes, and operational challenges.
  • Solution oriented
  • Regulatory & Compliance Expertise
    • Strong knowledge of GEP
    • Understanding of RA/MOH and local regulatory frameworks
    • Interpret and apply protocol requirements across diverse regions as applicable

P95 and Julius Clinical have recently joined forces, bringing together two highly complementary organizations with a shared mission: advancing global health through high‑quality epidemiological research and clinical trials.
P95, founded in 2011 and headquartered in Belgium, is a global leader in epidemiology, vaccines, and infectious disease research. With offices across Europe, North America, South America, Africa, and Southeast Asia, P95 supports public health agencies, pharmaceutical companies, academic institutions, and global organizations such as WHO and the European Commission. Our work focuses on generating timely, pragmatic, and actionable insights to improve access to safe and effective vaccines.
Julius Clinical, founded in 2008 and based in Zeist, The Netherlands, is a leading clinical CRO known for its strong scientific leadership and operational excellence. With more than 400 clinical trials conducted and over 300,000 participants enrolled worldwide, Julius Clinical specializes in central nervous system, cardio‑metabolic, renal, and rare diseases, working closely with biotech and mid‑sized pharma partners.
Together, we form a global, science‑driven organization offering an integrated portfolio of epidemiological and clinical research services. Our teams combine deep scientific expertise, operational excellence, and a shared passion for improving healthcare outcomes.
P95 and Julius Clinical (JC) are part of the Ampersand Capital Partners portfolio, a healthcare‑focused private equity firm.
We are united by a commitment to scientific rigor, innovation, and meaningful impact and we are excited to welcome new colleagues who share our ambition to improve global health.